- 0208 903 4819
- Weekday Hours: 10AM - 5PM
Polycystic ovarian syndrome (PCOS) is a condition in which the ovaries overproduce androgens, or
male sex hormones, which are typically seen in modest amounts in women. Numerous tiny cysts, or
sacs packed with fluid, develop in the ovaries and are referred to as polycystic ovaries.
PCOS, or polycystic ovarian syndrome, is thought to impact 7-8% of women who are fertile. Worldwide,
up to 70% of afflicted women go undetected.
Girls and women with PCOS are troubled with excessive facial hair, irregular periods and infertility when
they are young. As they grow older they are more prone to develop type 2 diabetes, heart attack and stroke.
Girls and women with PCOS gain weight and also struggle to lose weight.
Several studies have shown that weight loss helps to improve the hormonal profile and symptoms associated
with PCOS. Weight reduces acne and facial hair. In addition the risk of infertility and type 2 diabetes is reduced.
Polycystic ovarian syndrome (PCOS) is a condition in which the ovaries overproduce androgens, or male sex hormones, which are typically seen in modest amounts in women. Numerous tiny cysts, or sacs packed with fluid, develop in the ovaries and are referred to as polycystic ovaries.
PCOS, or polycystic ovarian syndrome, is thought to impact 7-8% of women who are fertile. Worldwide, up to 70% of afflicted women go undetected.
Girls and women with PCOS are troubled with excessive facial hair, irregular periods and infertility when they are young. As they grow older they are more prone to develop type 2 diabetes, heart attack and stroke.
Girls and women with PCOS gain weight and also struggle to lose weight.
Several studies have shown that weight loss helps to improve the hormonal profile and symptoms associated
with PCOS. Weight reduces acne and facial hair. In addition the risk of infertility and type 2 diabetes is reduced.
Mounjaro can be useful in managing women with PCOS weight gain. After the doctor reviews the patient in a consultation, it will determine if the patient is suitable to use the medication. A medical background check is required so that the patient is 100% safe to take the medication. The patient would start on the starter dose of 2.5mg if approved for Mounjaro
Mounjaro can be useful in managing women with PCOS weight gain. After the doctor reviews the patient in a consultation, it will
determine if the patient is suitable to use the medication. A medical background check is required so that the patient is 100% safe to
take the medication. The patient would start on the starter dose of 2.5mg if approved for Mounjaro
Mounjaro works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic
polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help to control blood sugar levels by
increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.
Increasing insulin secretion: Mounjaro stimulates the release of insulin from the pancreas, which helps to
lower blood sugar levels.
Slowing gastric emptying: Mounjaro slows down the movement of food from the stomach into the small
intestine, which helps you feel full for longer and eat less.
Suppressing glucagon secretion: Mounjaro reduces the release of glucagon from the pancreas, which helps to
prevent the liver from releasing too much sugar into the bloodstream.
Mounjaro works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help to control blood sugar levels by increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.
Increasing insulin secretion:
Mounjaro stimulates the release of insulin from the pancreas, which helps to lower blood sugar levels.
Slowing gastric emptying:
Mounjaro slows down the movement of food from the stomach into the small
intestine, which helps you feel full for longer and eat less.
Suppressing glucagon secretion:
Mounjaro reduces the release of glucagon from the pancreas, which helps to prevent the liver from releasing too much sugar into the bloodstream.
Studies have indicated that weight loss after glucagon-like peptide-1 receptor (GLP-1R) agonist medication may improve the metabolic characteristics of PCOS. It is thought that tirzepatide, a dual
GLP-GIP (gastric inhibitory polypeptide) receptor agonist, could one day be used to treat PCOS because of its striking similarities to GLP-1R agonists in terms of mechanism of action.
Studies have indicated that weight loss after glucagon-like peptide-1 receptor (GLP-1R) agonist medication may improve the metabolic characteristics of PCOS. It is thought that tirzepatide, a dual GLP-GIP (gastric inhibitory polypeptide) receptor agonist, could one day be used to treat PCOS because of its striking similarities to GLP-1R agonists in terms of mechanism of action.
Before recommending Mounjaro for weight management, medical professionals will evaluate a number of aspects, including general health and BMI. If the patient meets the eligibility requirements and the medicine is deemed appropriate for managing their weight, they can be prescribed Mounjaro. There maybe a few factors preventing the prescribing of Mounjaro such as Thyroid cancer or any medical conditions which could be a health risk.
Before recommending Mounjaro for weight management, medical professionals will evaluate a number of aspects, including general health and BMI. If the patient meets the eligibility requirements and the medicine is deemed appropriate for managing their weight, they can be prescribed Mounjaro. There maybe a few factors preventing the prescribing of Mounjaro such as Thyroid cancer or any medical conditions which could be a health risk.
Read our articles on Mounjaro and Wegovy if you would like to learn more about the benefits, the research and case studies.
Videos created by our chief doctor on managing and understanding Mounjaro to help you achieve the best outcomes possible.
Book an Appointment Today
All consultations and prescriptions are carried out by GMC registered medical practitioners.
All dispensing and shipping of medicines are completed by a UK licensed, GPhC registered Pharmacy no: 9011284.
CloudRx is our partner pharmacy and prescribing service.
*Disclaimer: Results may vary from person to person depending on individual engagement and commitment to the programme.
The content of this website is provided for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice. Do not use the information on this website for diagnosing or treating any medical or health related condition. If you have or suspect you have a medical problem, promptly contact your healthcare provider.
© 2023 The London Obesity Clinic
